Steve Schonfeld’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$196K Buy
+13,563
New +$233K ﹤0.01% 2381
2022
Q4
– Sell
-6,600
Closed -$370K – 3033
2022
Q3
$370K Buy
+6,600
New +$436K ﹤0.01% 1953
2021
Q4
– Sell
-2,200
Closed -$203K – 2562
2021
Q3
$203K Sell
2,200
-500
-19% -$48.1K ﹤0.01% 1755
2021
Q2
$277K Buy
+2,700
New +$271K ﹤0.01% 1515
2019
Q3
– Sell
-2,700
Closed -$214K – 1253
2019
Q2
$214K Sell
2,700
-2,700
-50% -$214K 0.01% 873
2019
Q1
$453K Buy
5,400
+952
+21% +$99.4K 0.02% 721
2018
Q4
$524K Buy
4,448
+1,248
+39% +$144K 0.02% 644
2018
Q3
$386K Buy
+3,200
New +$397K 0.02% 629

Other funds holding USNA

Steve Schonfeld's USNA Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Usana Health Sciences (USNA) in Q3 2026: 13,563 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #2381 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in USNA as recently as Q3 2022.

Steve Schonfeld first reported a position in USNA in Q3 2018 and has held it in 8 quarters since. The position peaked at $524K in Q4 2018. 128 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • Steve Schonfeld held 13,563 shares of Usana Health Sciences worth $196K as of Q3 2026.
  • Usana Health Sciences was a new Steve Schonfeld position in Q3 2026.
  • Usana Health Sciences made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2381 holding.
  • Steve Schonfeld first reported a position in Usana Health Sciences in Q3 2018 and has held it in 8 quarters since.
  • Steve Schonfeld's Usana Health Sciences position peaked at $524K in Q4 2018.
  • 128 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.